BTR Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.4M | Buy |
46,169
+44
| +0.1% | +$4.36K | 0.69% | 42 |
|
|
2022
Q2 | $4.27M | Sell |
46,125
-17,869
| -28% | -$1.74M | 0.61% | 43 |
|
|
2022
Q1 | $6.48M | Sell |
63,994
-41,197
| -39% | -$4.33M | 0.8% | 38 |
|
|
2021
Q4 | $10.9M | Sell |
105,191
-5,343
| -5% | -$494K | 1.22% | 31 |
|
|
2021
Q3 | $9.38M | Hold |
110,534
| – | – | 1.16% | 32 |
|
|
2021
Q2 | $9.22M | Buy |
110,534
+27,725
| +33% | +$2.27M | 1.15% | 32 |
|
|
2021
Q1 | $6.23M | Buy |
82,809
+1,485
| +2% | +$108K | 0.91% | 32 |
|
|
2020
Q4 | $5.55M | Sell |
81,324
-2,555
| -3% | -$166K | 0.87% | 34 |
|
|
2020
Q3 | $4.9M | Sell |
83,879
-978
| -1% | -$60.9K | 0.87% | 36 |
|
|
2020
Q2 | $5.51M | Sell |
84,857
-630
| -0.7% | -$39.7K | 1.04% | 33 |
|
|
2020
Q1 | $5.07M | Sell |
85,487
-2,575
| -3% | -$172K | 1.12% | 30 |
|
|
2019
Q4 | $6.54M | Sell |
88,062
-5,595
| -6% | -$393K | 1.13% | 34 |
|
|
2019
Q3 | $5.91M | Sell |
93,657
-1,806
| -2% | -$107K | 1.11% | 32 |
|
|
2019
Q2 | $5.2M | Sell |
95,463
-2,031
| -2% | -$109K | 0.97% | 36 |
|
|
2019
Q1 | $5.26M | Sell |
97,494
-6,267
| -6% | -$387K | 1.01% | 36 |
|
|
2018
Q4 | $6.8M | Sell |
103,761
-37,909
| -27% | -$2.83M | 1.43% | 26 |
|
|
2018
Q3 | $11.2M | Buy |
141,670
+2,052
| +1% | +$147K | 1.94% | 19 |
|
|
2018
Q2 | $8.98M | Buy |
139,618
+1,420
| +1% | +$93.6K | 1.73% | 25 |
|
|
2018
Q1 | $8.6M | Buy |
138,198
+4,441
| +3% | +$319K | 1.72% | 24 |
|
|
2017
Q4 | $9.7M | Sell |
133,757
-14,683
| -10% | -$1.07M | 1.9% | 19 |
|
|
2017
Q3 | $12.1M | Buy |
148,440
+2,860
| +2% | +$226K | 2.46% | 11 |
|
|
2017
Q2 | $11.7M | Buy |
145,580
+2,550
| +2% | +$201K | 2.4% | 11 |
|
|
2017
Q1 | $11.2M | Sell |
143,030
-6,607
| -4% | -$527K | 2.35% | 10 |
|
|
2016
Q4 | $13.3M | Hold |
149,637
| – | – | 2.99% | 4 |
|
|
2016
Q3 | $13.3M | Buy |
149,637
+9,845
| +7% | +$929K | 2.99% | 4 |
|
|
2016
Q2 | $13.4M | Buy |
139,792
+35,920
| +35% | +$3.58M | 3.07% | 3 |
|
|
2016
Q1 | $10.8M | Buy |
103,872
+1,435
| +1% | +$140K | 2.5% | 9 |
|
|
2015
Q4 | $10M | Buy |
102,437
+48,430
| +90% | +$4.74M | 2.28% | 11 |
|
|
2015
Q3 | $5.21M | Buy |
54,007
+7,100
| +15% | +$746K | 1.25% | 30 |
|
|
2015
Q2 | $4.92M | Sell |
46,907
-2,871
| -6% | -$293K | 1.16% | 36 |
|
|
2015
Q1 | $5.14M | Buy |
49,778
+17,289
| +53% | +$1.75M | 1.25% | 27 |
|
|
2014
Q4 | $3.13M | Sell |
32,489
-4,612
| -12% | -$406K | 0.85% | 44 |
|
|
2014
Q3 | $2.95M | Sell |
37,101
-297
| -0.8% | -$23.4K | 0.82% | 45 |
|
|
2014
Q2 | $2.82M | Sell |
37,398
-9,060
| -20% | -$685K | 0.77% | 46 |
|
|
2014
Q1 | $3.48M | Buy |
46,458
+600
| +1% | +$42.4K | 1.01% | 41 |
|
|
2013
Q4 | $3.28M | Sell |
45,858
-322
| -0.7% | -$20.7K | 0.94% | 43 |
|
|
2013
Q3 | $2.62M | Sell |
46,180
-3,520
| -7% | -$210K | 0.82% | 45 |
|
|
2013
Q2 | $2.84M | Buy |
+49,700
| New | +$2.88M | 0.88% | 41 |
|
Other funds holding CVS
BTR Capital Management's CVS Position: Q3 2022 in Review
BTR Capital Management increased its CVS Health (CVS) stake by 0.1% in Q3 2022, buying an estimated $4.36K and bringing the position to 46,169 shares worth $4.4M. The position accounts for 0.69% of the portfolio, ranked #42.
BTR Capital Management first reported a position in CVS in Q2 2013 and has held it in 38 quarters since. The position peaked at $13.4M in Q2 2016. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.
- BTR Capital Management held 46,169 shares of CVS Health worth $4.4M as of Q3 2022.
- BTR Capital Management bought 44 CVS Health shares in Q3 2022, an estimated $4.36K.
- CVS Health made up 0.69% of BTR Capital Management's portfolio in Q3 2022, its #42 holding.
- BTR Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 38 quarters since.
- BTR Capital Management's CVS Health position peaked at $13.4M in Q2 2016.
- 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.
Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.